An orally bioavailable small molecule antagonist of VISTA and VSIG8 signaling pathways shows potent anti-tumor activity

被引：0
|
作者：
Sasikumar, Pottayil [1 ]
Naremaddepalli, Sudarshan [1 ]
Ramachandra, Raghuveer [1 ]
Gowda, Nagesh [1 ]
Alluri, Govardhan [1 ]
Yerramsetti, Manikyalarao [1 ]
Adurthi, Sreenivas [1 ]
Mani, Jiju [1 ]
Nair, Rashmi [1 ]
Dhudashiya, Amit [1 ]
Dodheri, Samiulla [1 ]
Gowda, Nagaraj [1 ]
Ramachandra, Murali [1 ]
机构：
[1] Aurigene Discovery Technol Ltd, Bangalore, Karnataka, India
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P354
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Small Molecule Inhibitor of ITK Disrupts TCR Signaling and Demonstrates Anti-Tumor Efficacy
    Faris, Mary
    Malyankar, Uriel M.
    Zeng, Qingping
    Flynn, Gary A.
    Fuer, Gerold
    Kertesz, Nathalie L.
    Vuga, Danka
    Lee, Sandra
    Rosario, Darlene
    Bot, Adrian
    BLOOD, 2010, 116 (21) : 1603 - 1604
  • [32] Discovery and characterization of a new potent orally available CdC7 inhibitor with anti-tumor activity
    Montagnoli, A.
    Vanotti, E.
    Rainoldi, S.
    Marchesi, V.
    Ciavolella, A.
    Croci, V.
    Patton, V.
    Albanese, C.
    Santocanale, C.
    Moll, J.
    EJC SUPPLEMENTS, 2008, 6 (12): : 116 - 116
  • [33] Discovery of novel and potent TEAD inhibitors, orally available small molecules with anti-tumor activity in hippo pathway-dysregulated cancers
    Moon, Sungho
    Cho, Seon Yeon
    Kim, Minhye
    Beak, Soojeong
    Kim, Jinhyuk
    Kim, Yongchan
    Park, Sungil
    Kim, Jung-In
    Kim, Hanseong
    Lee, In Sang
    No, Kyoung Tai
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [34] Discovery of Potent and Orally Bioavailable Small Molecule Antagonists of Toll-like Receptors 7/8/9 (TLR7/8/9)
    Mussari, Christopher P.
    Dodd, Dharmpal S.
    Sreekantha, Ratna Kumar
    Pasunoori, Laxman
    Wan, Honghe
    Posy, Shana L.
    Critton, David
    Ruepp, Stefan
    Subramanian, Murali
    Watson, Andrew
    Davies, Paul
    Schieven, Gary L.
    Salter-Cid, Luisa M.
    Srivastava, Ratika
    Tagore, Debarati Mazumder
    Dudhgaonkar, Shailesh
    Poss, Michael A.
    Carter, Percy H.
    Dyckman, Alaric J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (09): : 1751 - 1758
  • [35] LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders
    Rorick-Kehn, Linda M.
    Witkin, Jeffrey M.
    Statnick, Michael A.
    Eberle, Elizabeth L.
    McKinzie, Jamie H.
    Kahl, Steven D.
    Forster, Beth M.
    Wong, Conrad J.
    Li, Xia
    Crile, Robert S.
    Shaw, David B.
    Sahr, Allison E.
    Adams, Benjamin L.
    Quimby, Steven J.
    Diaz, Nuria
    Jimenez, Alma
    Pedregal, Concepcion
    Mitch, Charles H.
    Knopp, Kelly L.
    Anderson, Wesley H.
    Cramer, Jeffrey W.
    Mc Kinzie, David L.
    NEUROPHARMACOLOGY, 2014, 77 : 131 - 144
  • [36] CCX559 is a potent orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity.
    Li, Chris
    Vilalta, Marta
    Ertl, Linda S.
    Wang, Yu
    Zeng, Yibin
    Fan, Pingchen
    Lange, Christopher
    McMurtrie, Darren
    Yang, Ju
    Lui, Rebecca
    Scamp, Ryan
    Chhina, Vicky
    Kumamoto, Alice
    Ong, Ryan
    Dang, Ton
    Easterday, Ashton
    Zhao, Niky
    Liu, Shirley
    Singh, Rajinder
    Charo, Israel
    Sullivan, Kathleen
    Schall, Thomas J.
    Zhang, Penglie
    CANCER RESEARCH, 2021, 81 (13)
  • [37] Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma
    Patwardhan, Parag P.
    Ivy, Kathryn S.
    Musi, Elgilda
    de Stanchina, Elisa
    Schwartz, Gary K.
    ONCOTARGET, 2016, 7 (04) : 4093 - 4109
  • [38] Identification and preclinical characterization of NMS-P626, a potent, selective and orally bioavailable TrkA inhibitor with anti-tumor activity in a TrkA-dependent colorectal cancer
    Ardini, E.
    Borgia, A. Lombardi
    De Ponti, C.
    Amboldi, N.
    Ballinari, D.
    Saccardo, M. B.
    Magnaghi, P.
    Pesenti, E.
    Isacchi, A.
    Galvani, A.
    EJC SUPPLEMENTS, 2010, 8 (07): : 39 - 40
  • [39] Anti-Tumor Activity of Novel Small Molecule Wnt Signaling Inhibitor, CWP232291, In Multiple Myeloma.
    Cha, Joo Young
    Jung, Ji-Eun
    Lee, Kwan-Hoo
    Briaud, Isabelle
    Tenzin, Fnu
    Jung, Hee Kyung
    Pyon, Younghee
    Lee, Donghee
    Chung, Jae Uk
    Lee, Jong Heun
    Oh, Se-Woong
    Jung, Kyung Yun
    Pai, Jin Keon
    Emami, Kathy
    BLOOD, 2010, 116 (21) : 1252 - 1252
  • [40] Potent antitumor activity of a novel and orally available small -molecule antagonist targeting the CD47/SIRPα pathway
    Sasikumar, Pottayil G.
    Gundala, Chennakrishnareddy
    Balasubramanian, Wesley R.
    Naremaddepalli, Sudarshan S.
    Bhumireddy, Archana
    Patil, Sandeep S.
    Dhudashiya, Amit A.
    Rayavarapu, Vijaysai
    Lakshminarasimhan, Anirudha
    Samiulla, Dodheri S.
    Aithal, Kiran
    Daginakatte, Girish
    Ramachandra, Murali
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
12345